AAAAAA
Results: 1-25/32
Authors:
ACAR JF
GOLDSTEIN FW
Citation: Jf. Acar et Fw. Goldstein, CONSEQUENCES OF INCREASING RESISTANCE TO ANTIMICROBIAL AGENTS, Clinical infectious diseases, 27, 1998, pp. 125-130
Authors:
WISE R
ACAR JF
ALDRIDGE KE
BARRY AL
DUNN DL
IRAVANI A
MEYERS BR
PALADINO JA
PEGRAM PS
PETERSON LR
WEINSTEIN RA
Citation: R. Wise et al., PANEL DISCUSSION - III - THE APOCALYPTIC BACTERIUM IS APPROACHING FAST - WHAT CAN WE DO, Infectious diseases in clinical practice, 7, 1998, pp. 184-187
Authors:
FIGLIOLINI C
ACAR JF
Citation: C. Figliolini et Jf. Acar, BACTERIAL-RESISTANCE TO ANTIBIOTHERAPY - THERAPEUTIC STANDPOINTS IN INTERNAL-MEDICINE, La Revue de medecine interne, 19(4), 1998, pp. 233-235
Authors:
MAINARDI JL
LACASSIN F
GUILLOY Y
GOLDSTEIN FW
LEPORT C
ACAR JF
VILDE JL
Citation: Jl. Mainardi et al., LOW-RATE OF CLOSTRIDIUM-DIFFICILE COLONIZATION IN AMBULATORY AND HOSPITALIZED HIV-INFECTED PATIENTS IN A HOSPITAL UNIT - A PROSPECTIVE SURVEY, The Journal of infection, 37(2), 1998, pp. 108-111
Authors:
ACAR JF
KAPLAN EL
OBRIEN TF
Citation: Jf. Acar et al., MONITORING AND MANAGEMENT OF BACTERIAL-RESISTANCE TO ANTIMICROBIAL AGENTS - A WORLD-HEALTH-ORGANIZATION-SYMPOSIUM - GENEVA, SWITZERLAND - 29 NOVEMBER 2 DECEMBER 1994 - INTRODUCTION, Clinical infectious diseases, 24, 1997, pp. 1-1
Authors:
ACAR JF
Citation: Jf. Acar, CONSEQUENCES OF BACTERIAL-RESISTANCE TO ANTIBIOTICS IN MEDICAL-PRACTICE, Clinical infectious diseases, 24, 1997, pp. 17-18
Authors:
ACAR JF
GOLDSTEIN FW
Citation: Jf. Acar et Fw. Goldstein, TRENDS IN BACTERIAL-RESISTANCE TO FLUOROQUINOLONES, Clinical infectious diseases, 24, 1997, pp. 67-73
Authors:
ACAR JF
KAPLAN EL
OBRIEN TF
Citation: Jf. Acar et al., MONITORING AND MANAGEMENT OF BACTERIAL-RESISTANCE TO ANTIMICROBIAL AGENTS - A WORLD-HEALTH-ORGANIZATION-SYMPOSIUM - CONCLUSION, Clinical infectious diseases, 24, 1997, pp. 176-176
Authors:
GOLDSTEIN FW
ACAR JF
Citation: Fw. Goldstein et Jf. Acar, ANTIMICROBIAL RESISTANCE AMONG LOWER RESPIRATORY-TRACT ISOLATES OF STREPTOCOCCUS-PNEUMONIAE - RESULTS OF A 1992-93 WESTERN-EUROPE AND USA COLLABORATIVE SURVEILLANCE STUDY, Journal of antimicrobial chemotherapy, 38, 1996, pp. 71-84
Authors:
SCHITO GC
ACAR JF
BAUERNFEIND A
DUVAL J
FINCH RG
FOCHT J
NICOLETTI G
PHILLIPS I
PRATTS G
SORIANO F
WIEDEMAN B
WISE R
Citation: Gc. Schito et al., A MULTINATIONAL EUROPEAN SURVEY ON THE IN-VITRO ACTIVITY OF RUFLOXACIN AND OTHER COMPARATIVE ANTIBIOTICS ON RESPIRATORY AND URINARY BACTERIAL PATHOGENS, Journal of antimicrobial chemotherapy, 38(4), 1996, pp. 627-639
Authors:
ACAR JF
ANDRIOLE VT
Citation: Jf. Acar et Vt. Andriole, NEW STRATEGIES IN INFECTIOUS-DISEASES - RATIONALE FOR THE USE OF NOVEL STREPTOGRAMINS - A SEMINAR-IN-PRINT, Drugs, 51, 1996, pp. 6-6
Authors:
GOLDSTEIN FW
ACAR JF
Citation: Fw. Goldstein et Jf. Acar, EPIDEMIOLOGY OF ANTIBIOTIC-RESISTANCE IN HAEMOPHILUS-INFLUENZAE, Microbial drug resistance, 1(2), 1995, pp. 131-135
Authors:
CHAIBI EB
MUGNIER P
KITZIS MD
GOLDSTEIN FW
ACAR JF
Citation: Eb. Chaibi et al., BRANHAMELLA-CATARRHALIS BETA-LACTAMASES A ND THEIR PHENOTYPIC IMPLICATIONS, Research in microbiology, 146(9), 1995, pp. 761-771
Authors:
COUTANTPERRONNE V
LUTZ V
MAINARDI JL
ACAR JF
KUGELSTADT P
GOLDSTEIN F
Citation: V. Coutantperronne et al., NOCARDIA MENINGITIS WITHOUT BRAIN-ABSCESS ON CT-SCAN, La Presse medicale, 24(27), 1995, pp. 1271-1271
Authors:
KITZIS MD
GOLDSTEIN FW
ISHIDA N
ACAR JF
Citation: Md. Kitzis et al., SYN987, SYN1193, AND SYN1253, NEW QUINOLONES HIGHLY-ACTIVE AGAINST GRAM-POSITIVE COCCI, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 209-213
Authors:
MAINARDI JL
GUTMANN L
ACAR JF
GOLDSTEIN FW
Citation: Jl. Mainardi et al., SYNERGISTIC EFFECT OF AMOXICILLIN AND CEFOTAXIME AGAINST ENTEROCOCCUS-FAECALIS, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1984-1987
Authors:
MAINARDI JL
GUTMANN L
ACAR JF
GOLDSTEIN FW
Citation: Jl. Mainardi et al., SYNERGISTIC EFFECT OF AMOXICILLIN AND CEFOTAXIME AGAINST ENTEROCOCCUS-FAECALIS (VOL 39, PG 1986, 1995), Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2835-2835
Authors:
MAINARDI JL
SHLAES DM
GOERING RV
SHLAES JH
ACAR JF
GOLDSTEIN FW
Citation: Jl. Mainardi et al., DECREASED TEICOPLANIN SUSCEPTIBILITY OF METHICILLIN-RESISTANT STRAINSOF STAPHYLOCOCCUS-AUREUS, The Journal of infectious diseases, 171(6), 1995, pp. 1646-1650
Authors:
LEHNERT F
MORTIER E
MOUSSEAUX E
OLLITRAULT J
GOLDSTEIN F
CARPENTIER A
ACAR JF
PAULYLAUBRY C
Citation: F. Lehnert et al., CORYNEBACTERIUM DIPHTERIAE ENDOCARDITIS C OMPLICATED BY SEPTIC ARTHRITIS AND CEREBRAL ABSCESS, Archives des maladies du coeur et des vaisseaux, 88(6), 1995, pp. 899-901
Authors:
GOLDSTEIN FW
ACAR JF
Citation: Fw. Goldstein et Jf. Acar, EPIDEMIOLOGY OF RESISTANCE TO DIAMINOPYRI MIDINES, Journal of chemotherapy, 6, 1994, pp. 85-89
Authors:
SOUSSY CJ
CLUZEL R
COURVALIN P
ACAR JF
BERGOGNEBEREZIN E
CHABBERT Y
COURTIEU A
DABERNAT H
DRUGEON H
DUVAL J
FLANDROIS JP
FLEURETTE J
GOLDSTEIN F
MEYRAN M
MOREL C
PHILIPPON A
SIROT J
THABAUT A
VERON M
Citation: Cj. Soussy et al., DEFINITION AND DETERMINATION OF IN-VITRO ANTIBIOTIC SUSCEPTIBILITY BREAKPOINTS FOR BACTERIA IN FRANCE, European journal of clinical microbiology & infectious diseases, 13(3), 1994, pp. 238-246
Authors:
PIC P
TIMSIT JF
MAINARDI JL
GOLDSTEIN FW
ACAR JF
CARLET J
Citation: P. Pic et al., SEPTICEMIA DUE TO FUSOBACTERIUM-NECROPHOR UM, La Presse medicale, 23(12), 1994, pp. 581-581
Authors:
LORTHOLARY O
EMMERICH J
BUUHOI A
GUTMANN L
FIESSINGER JN
ACAR JF
Citation: O. Lortholary et al., LACTOBACILLUS-CASEI SUBSPECIES CASEI NATI VE VALVE ENDOCARDITIS, Medecine et maladies infectieuses, 24(2), 1994, pp. 110-111
Authors:
MONZONMORENO C
ALAMO I
GOLDSTEIN FW
ACAR JF
VIOT M
SCHNEIDER M
BUSSY V
LION C
MINELLO C
LOBERA A
BOINEAU F
ROUSSELDELVALLEZ M
BEAL J
LEFEBVRE D
COULLIOUD D
VANDERAUWERA P
KLASTERSKY J
Citation: C. Monzonmoreno et al., PLASMID-MEDIATED RESISTANCE TO TRIMETHOPRIM IN ENTEROBACTERIACEAE ISOLATED IN GRAN-CANARIA, CANARY-ISLANDS (SPAIN), Medecine et maladies infectieuses, 24(12), 1994, pp. 1248-1252
Authors:
GUIBERT J
KITZIS MD
ACAR JF
Citation: J. Guibert et al., ANTIBACTERIAL ACTIVITY OF CIPROFLOXACIN I N THE URINE DURING 4 DAYS AFTER A SINGLE 500 MG AND 750 MG ORAL DOSE, Pathologie et biologie, 42(6), 1994, pp. 587-592